These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 19774497)

  • 1. Immunomodulatory therapies in neurologic critical care.
    McDaneld LM; Fields JD; Bourdette DN; Bhardwaj A
    Neurocrit Care; 2010 Feb; 12(1):132-43. PubMed ID: 19774497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of intravenous immunoglobulin for treatment of neurologic conditions: a systematic review.
    Fergusson D; Hutton B; Sharma M; Tinmouth A; Wilson K; Cameron DW; Hebert PC
    Transfusion; 2005 Oct; 45(10):1640-57. PubMed ID: 16181216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic plasma exchange in patients with neurologic diseases: retrospective multicenter study.
    Kaynar L; Altuntas F; Aydogdu I; Turgut B; Kocyigit I; Hacioglu SK; Ismailogullari S; Turgut N; Erkurt MA; Sari I; Oztekin M; Solmaz M; Eser B; Ersoy AO; Unal A; Cetin M
    Transfus Apher Sci; 2008 Apr; 38(2):109-15. PubMed ID: 18331814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Plasmapheresis in neurological diseases. Experience in 140 procedures in 47 patients].
    Nogales-Gaete J; Valenzuela D; Liendo F; Vidal P; Gil G; Sáez D
    Rev Med Chil; 2004 Mar; 132(3):295-8. PubMed ID: 15376565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current immune therapies of autoimmune disease of the nervous system with special emphasis to multiple sclerosis.
    Vass K
    Curr Pharm Des; 2012; 18(29):4513-7. PubMed ID: 22612753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Immunoglobulin Versus Plasmapheresis in Guillain-Barre Syndrome and Myasthenia Gravis: A Meta-Analysis.
    Ortiz-Salas P; Velez-Van-Meerbeke A; Galvis-Gomez CA; Rodriguez Q JH
    J Clin Neuromuscul Dis; 2016 Sep; 18(1):1-11. PubMed ID: 27552383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence-based guideline update: Plasmapheresis in neurologic disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
    Cortese I; Chaudhry V; So YT; Cantor F; Cornblath DR; Rae-Grant A
    Neurology; 2011 Jan; 76(3):294-300. PubMed ID: 21242498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurologic indications for therapeutic plasma exchange: 2013 update.
    Gwathmey K; Balogun RA; Burns T
    J Clin Apher; 2014 Aug; 29(4):211-9. PubMed ID: 24890467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic plasma exchange in patients with neurological diseases: multicenter retrospective analysis.
    Kaya E; Keklik M; Sencan M; Yilmaz M; Keskin A; Kiki I; Erkurt MA; Sivgin S; Korkmaz S; Okan V; Doğu MH; Unal A; Cetin M; Altuntaş F; Ilhan O
    Transfus Apher Sci; 2013 Jun; 48(3):349-52. PubMed ID: 23619327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mannose-binding Lectin Mediated Complement Pathway in Autoimmune Neurological Disorders.
    Farrokhi M; Dabirzadeh M; Dastravan N; Etemadifar M; Ghadimi K; Saadatpour Z; Rezaei A
    Iran J Allergy Asthma Immunol; 2016 Jun; 15(3):251-6. PubMed ID: 27424141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmapheresis Versus Intravenous Immunoglobulin in Patients With Autoimmune Neuromuscular and Neuro-immunological Conditions.
    Zubair AS; Rethana M; Ma A; McAlpine LS; Abulaban A; Munro BS; Patwa HS; Nowak RJ; Roy B
    J Clin Neuromuscul Dis; 2023 Sep; 25(1):11-17. PubMed ID: 37611265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current treatment of neuromuscular diseases.
    Kokontis L; Gutmann L
    Arch Neurol; 2000 Jul; 57(7):939-43. PubMed ID: 10891975
    [No Abstract]   [Full Text] [Related]  

  • 13. The top clinical trial opportunities in therapeutic apheresis and neurology.
    Morgan SM; Shaz BH; Pavenski K; Meyer EK; Delaney M; Szczepiorkowski ZM
    J Clin Apher; 2014 Dec; 29(6):331-5. PubMed ID: 24899381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The use of therapeutic apheresis in neurological diseases and comparison between plasma exchange and immunoadsorption].
    Loschiavo C; Grecò M; Polo A; Del Colle R
    G Ital Nefrol; 2015; 32(1):. PubMed ID: 25774587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Available laboratory tests of neurological diseases involving autoimmune].
    Shibuya S; Wakayama Y
    Rinsho Byori; 2003 Feb; Suppl 124():81-5. PubMed ID: 12710037
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapeutic plasma exchange in the neurologic intensive care setting recommendation for clinical practice.
    Kes P; Basić-Kes V; Basić-Jukić N; Demarin V
    Acta Clin Croat; 2012 Mar; 51(1):137-53. PubMed ID: 22920015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune mediated diseases and immune modulation in the neurocritical care unit.
    von Geldern G; McPharlin T; Becker K
    Neurotherapeutics; 2012 Jan; 9(1):99-123. PubMed ID: 22161307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review: the use of rituximab in neuromuscular diseases.
    Ibrahim H; Dimachkie MM; Shaibani A
    J Clin Neuromuscul Dis; 2010 Dec; 12(2):91-102. PubMed ID: 21386778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic strategies for myasthenia gravis.
    Keys PA; Blume RP
    DICP; 1991 Oct; 25(10):1101-8. PubMed ID: 1803801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurologic indications for therapeutic plasma exchange: an update.
    Gwathmey K; Balogun RA; Burns T
    J Clin Apher; 2011; 26(5):261-8. PubMed ID: 21915895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.